3-Methoxytyramine: An independent prognostic biomarker that associates with high-risk disease and poor clinical outcome in neuroblastoma patients

IRN Verly; ABP van Kuilenburg; N Abeling; SMI Goorden; M Fiocco; FM Vaz; MM Noesel; C.M. Zwaan; GJL Kaspers; JHM Merks; HN Caron; GAM Tytgat

doi:10.1016/j.ejca.2017.11.025

3-Methoxytyramine: An independent prognostic biomarker that associates with high-risk disease and poor clinical outcome in neuroblastoma patients

IRN Verly, ABP van Kuilenburg, N Abeling, SMI Goorden, M Fiocco, FM Vaz, MM Noesel, C.M. Zwaan, GJL Kaspers, JHM Merks, HN Caron, GAM Tytgat

Pediatrics

Research output: Contribution to journal › Article › Academic › peer-review

20 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	102-110
Number of pages	9
Journal	European Journal of Cancer
Volume	90
DOIs	https://doi.org/10.1016/j.ejca.2017.11.025
Publication status	Published - 2018

Research programs

EMC MM-02-54-03

Access to Document

10.1016/j.ejca.2017.11.025

http://hdl.handle.net/1765/103631

Cite this

Verly, IRN., van Kuilenburg, ABP., Abeling, N., Goorden, SMI., Fiocco, M., Vaz, FM., Noesel, MM., Zwaan, C. M., Kaspers, GJL., Merks, JHM., Caron, HN., & Tytgat, GAM. (2018). 3-Methoxytyramine: An independent prognostic biomarker that associates with high-risk disease and poor clinical outcome in neuroblastoma patients. European Journal of Cancer, 90, 102-110. https://doi.org/10.1016/j.ejca.2017.11.025

@article{4950ed621e4c4e1182e830fca1d32b81,

title = "3-Methoxytyramine: An independent prognostic biomarker that associates with high-risk disease and poor clinical outcome in neuroblastoma patients",

author = "IRN Verly and {van Kuilenburg}, ABP and N Abeling and SMI Goorden and M Fiocco and FM Vaz and MM Noesel and C.M. Zwaan and GJL Kaspers and JHM Merks and HN Caron and GAM Tytgat",

year = "2018",

doi = "10.1016/j.ejca.2017.11.025",

language = "Undefined/Unknown",

volume = "90",

pages = "102--110",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

}

Verly, IRN, van Kuilenburg, ABP, Abeling, N, Goorden, SMI, Fiocco, M, Vaz, FM, Noesel, MM, Zwaan, CM, Kaspers, GJL, Merks, JHM, Caron, HN & Tytgat, GAM 2018, '3-Methoxytyramine: An independent prognostic biomarker that associates with high-risk disease and poor clinical outcome in neuroblastoma patients', European Journal of Cancer, vol. 90, pp. 102-110. https://doi.org/10.1016/j.ejca.2017.11.025

TY - JOUR

T1 - 3-Methoxytyramine: An independent prognostic biomarker that associates with high-risk disease and poor clinical outcome in neuroblastoma patients

AU - Verly, IRN

AU - van Kuilenburg, ABP

AU - Abeling, N

AU - Goorden, SMI

AU - Fiocco, M

AU - Vaz, FM

AU - Noesel, MM

AU - Zwaan, C.M.

AU - Kaspers, GJL

AU - Merks, JHM

AU - Caron, HN

AU - Tytgat, GAM

PY - 2018

Y1 - 2018

U2 - 10.1016/j.ejca.2017.11.025

DO - 10.1016/j.ejca.2017.11.025

M3 - Article

SN - 0959-8049

VL - 90

SP - 102

EP - 110

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -